We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
| Name | Symbol | Market | Type |
|---|---|---|---|
| Sanofi | NASDAQ:SNY | NASDAQ | Depository Receipt |
| Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.57 | -1.14% | 49.46 | 48.07 | 50.30 | 49.47 | 48.27 | 49.04 | 4,596,609 | 01:00:00 |
From May 2019 to May 2024
PARIS, February 9, 2016 /PRNewswire/ --
Sanofi, a global and diversified healthcare leader, reports annual results for 2015. CEO Olivier Brandicourt comments on results and outlook.
Watch video interview and read transcript: http://www.eurobusinessmedia.com/ceo-direct/sanofi/2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire
Topics covered in the interview include:
- 2015 results
- Strategic roadmap update
- Sanofi Genzyme
- Consumer Healthcare
- Launches
- Diabetes
- R&D pipeline
- Dividend
About Sanofi
Sanofi, a global healthcare leader, discovers, develops and distributes therapeutic solutions focused on patients' needs. Sanofi has core strengths in the field of healthcare with seven growth platforms: diabetes solutions, human vaccines, innovative drugs, consumer healthcare, emerging markets, animal health and the new Genzyme. Sanofi is listed in Paris (EURONEXT: SAN) and in New York (NYSE: SNY).
SOURCE Sanofi
Copyright 2016 PR Newswire
1 Year Sanofi Chart |
1 Month Sanofi Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
